What You Should Know:
– LucyRx, a next-generation pharmacy benefit manager (PBM), announced it has acquired CerpassRx, a leading PBM known for its customized pharmacy solutions and clinical programs.
– The acquisition, which closed on July 15, 2025, positions the newly combined company to serve a broad range of clients, from health plans and self-funded employers to Taft-Hartley plans.
– The transaction was financed through a combination of equity and debt, with equity investors including New Mountain Capital and TTV Capital, a technology-focused venture capital firm specializing in fintech.
A New Chapter for PBMs: Innovation and Partnership
The combination of LucyRx and CerpassRx marks the creation of a new kind of PBM powerhouse, designed to meet the evolving demands of the market with a “technology-first, partner-centric approach”. The newly merged entity aims to deliver superior client and member experiences through a combination of innovative technology, clinical excellence, and transparent, client-aligned business practices.
CerpassRx, based in Dallas, Texas, has built a strong reputation for offering flexible, tailored pharmacy solutions and clinical programs to its diverse client base. These solutions span from mail-order and specialty pharmacy to clinical programs like opioid management and formulary optimization. The company’s focus on clinical value and client partnership aligns seamlessly with LucyRx’s vision.
Following the acquisition, the combined entity will serve a wide range of clients, from mid-market health plans to large, self-funded employers and Taft-Hartley plans. It will also focus on leveraging innovative technologies to improve member engagement, drive greater transparency, and simplify pharmacy benefit management for all stakeholders.
